Purchase Order 75D30124P00060
Award Date 8/5/24
Potential Completion Date 9/30/24
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Roche Diagnostics Corporation received a delivery order valued at $130,151.30 from the Centers for Disease Control and Prevention (CDC) on August 21, 2024, for Roche COBAS R 4800 and COBAS R 6800 molecular diagnostic systems and associated reagents. These validated platforms are approved by PEPFAR (President's Emergency Plan for AIDS Relief), WHO prequalified, and FDA-cleared for HIV viral load and early infant diagnosis (EID) testing. The order is a child contract under the GSA Critical...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $572,044.24 by the Centers for Disease Control and Prevention (CDC) Pittsburgh for maintenance services on COBAS HIV equipment with operations support. The contract, awarded on July 17, 2024, carries an ultimate completion date of September 4, 2028, and will be performed in Castleton, Indiana. This award represents a non-competitive procurement with no set-aside designation, reflecting Roche's established...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $105,921.20 contract is for sample reagents with a completion date of November 7, 2022. This award was not set aside for any socioeconomic category. Roche Diagnostics has held numerous federal contracts, including...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- The Centers for Disease Control and Prevention (CDC) Atlanta awarded a $150,782.40 firm fixed-price purchase order to Roche Diagnostics Corporation on April 1, 2023, for diagnostic services and support under a service agreement structure. The contract extends through March 31, 2027, with performance occurring at Roche's facility in Chamblee, Georgia. This award represents a direct procurement without set-aside designation, reflecting open competition in the federal diagnostic marketplace. As a...
- The Centers for Disease Control and Prevention (CDC) awarded a $144,511 purchase order to Roche Diagnostics Corporation for reagents and laboratory supplies. As the prime contractor, Roche will provide the requested products to support CDC's disease prevention and health promotion efforts. The firm fixed price contract has a one year period of performance starting in September 2023. No subcontractors or set aside designations were indicated. The award falls under HHS-CDC's broader public...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...
- This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...